TFThomas L. Forbes

Thomas L. Forbes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomas L. Forbes has a total of 199 co-authors. Here are the top co-authors by number of shared publications:

  • Matthew G. Doyle

    Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Ontario, Canada; Division of Vascular Surgery, Department of Surgery, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada

    5 shared publications
  • Cristina H. Amon

    Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada; Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Ontario, Canada

    4 shared publications
  • Sean A. Crawford

    Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada; Division of Vascular Surgery, University Health Network, Peter Munk Cardiac Centre, University of Toronto, Toronto, Ontario, Canada

    4 shared publications
  • Ahmed Kayssi

    Division of Vascular Surgery, University of Toronto, Toronto, Ontario, Canada

    3 shared publications
  • Charles de Mestral

    University of Toronto

    3 shared publications
  • Graham Roche-Nagle

    Vascular Surgery, Toronto General Hospital, Toronto, Ontario, Canada

    3 shared publications

Latest Publications

  • Open Access

    Transatlantic Delphi Consensus on the Common Iliac Artery Sealing Zone in Endovascular Aorto-Iliac Aneurysm Repair (the DECIDE Study)

    by Maria-Annette Kooijman, Mario D’ORia, Luca Bertoglio, Isabelle Van Herzeele, Ross Milner, Jean-Paul P.M. de Vries, Richte C.L. Schuurmann, Gautam Agarwal, Michele Antonello, Frederico Bastos Goncalves, et al.

    Objective: Knowledge of hostile factors and their influence on long-term seal in the iliac landing zone is limited. Currently endorsed clinical practice guidelines lack structural evidence on how the iliac landing zone should be assessed in the pre-, intra-, and postoperative phases. The goal of this study was to obtain an international, expert-based consensus on the definition of a hostile iliac landing zone, on how to size and plan stent-grafts to optimize sustainable distal seal, and on the postprocedural follow-up protocol. Methods: Delphi consensus methodology was used, involving a panel of international vascular surgeons experienced in endovascular aneurysm repair (EVAR). The first round consisted of open-ended and multiple-choice questions to explore current practices, with subsequent rounds refining statements through a 4-point Likert scale. Consensus was defined as >75% agreement or disagreement, and the analysis included stability testing and strength of consensus. Results: The study engaged 77 international vascular surgeons, reflecting diverse geographic locations and hospital affiliations. Consensus was achieved on critical preoperative planning elements for EVAR, including a clear definition for a hostile iliac landing zone. The importance of computed tomography angiography for postoperative follow-up imaging was emphasized, including evaluating distal seal length and recommending specific timing for follow-up computed tomography scans and intervention strategies for diminishing iliac seal. Conclusions: This international expert-based Delphi consensus establishes a comprehensive set of consensus-driven recommendations focused on the definition and management of hostile iliac landing zones in EVAR. The key recommendation of this study is the definition of a hostile iliac landing zone as short (24 mm), or conical (>10% diameter difference along the landing zone). Although consensus was achieved on several critical aspects, the study also reveals ongoing debates and considerations that warrant further exploration, including how to tackle diminishing seal without a type IB endoleak. Clinical Impact: This Delphi consensus introduces a standardized definition of a hostile iliac landing zone as short (24 mm), or conical (>10% diameter difference), clinicians now have a clearer framework for assessing complex anatomies. This study provides a comprehensive set of consensus-driven recommendations focused on the definition and management of hostile iliac landing zones in EVAR which gives guidance where current guidelines lack specificity, particularly for distal iliac sealing. The study also reveals ongoing debates and considerations that warrant further exploration, including how to tackle diminishing seal without a type IB endoleak.


  • In memoriam: K. Wayne Johnston

    by Barry Rubin, Thomas F. Lindsay, Graham Roche-Nagle, Thomas L. Forbes, Paul Walker

  • Analysis of spin in vascular surgery randomized controlled trials with nonsignificant outcomes

    by Jessica Nguyen, Allen Li, Derrick Y. Tam, Thomas L. Forbes


  • A modeling framework for computational simulations of thoracic endovascular aortic repair

    by Negin Shahbazian, Matthew G. Doyle, Thomas L. Forbes, Cristina H. Amon

    Thoracic endovascular aortic repair (TEVAR) is a minimally invasive treatment for thoracic aortic conditions including aneurysms and is associated with a number of postoperative stent graft related complications. Computational simulations of TEVAR have the potential to predict surgical outcomes and complications preoperatively. When using simulations for stent graft design and prediction of complications in a population, it is difficult to generalize patient‐specific TEVAR computational models due to patient variability. This study proposes a novel modeling framework for creating realistic population‐based computational models of TEVAR focused on aneurysms that allow for developing various clinically relevant geometric configurations and scenarios that are not easily attainable with limited patient data. The framework includes a methodology for developing population‐based thoracic aortic geometries and defining age‐dependent aortic tissue material models, as well as detailed steps and boundary conditions for finite element modeling of stent graft deployment during TEVAR. The simulation framework is illustrated for predicting the formation of a bird‐beak configuration, a wedge‐shaped gap at the proximal end of the deployed stent graft in TEVAR that leads to incomplete seal. A baseline TEVAR simulation model was developed along with three simulations in which the value of aortic curvature, aortic arch angle, or aortic tissue properties varied from the baseline model. Analyzing the length and angle of the bird‐beak configuration in each case shows that the bird‐beak size is sensitive to different values of the aortic geometry highlighting the importance of using realistic parameter values.


  • A multicenter retrospective cohort study of blunt traumatic injury to the common or internal carotid arteries

    by Jean Jacob-Brassard, Mohammed Al-Omran, Barbara Haas, Avery B. Nathens, David Gomez, Andrew D. Dueck, Thomas L. Forbes, Charles de Mestral


  • Calibration of an Electrical Analog Model of Liver Hemodynamics in Fontan Patients

    by Elyar Abbasi Bavil, Matthew G. Doyle, Charlotte Debbaut, Rachel M. Wald, Luc Mertens, Thomas L. Forbes, Cristina H. Amon

    Fontan associated liver disease is a common complication in patients with Fontan circulation, who were born with a single functioning heart ventricle. The hepatic venous pressure gradient (HVPG) is used to assess liver health and is a surrogate measure of the pressure gradient across the entire liver (portal pressure gradient (PPG)). However, it is thought to be inaccurate in Fontan patients. The main objectives of this study were (1) to apply an existing detailed lumped parameter model (LPM) of the liver to Fontan patients using patient-specific clinical data and (2) to determine whether HVPG is a suitable measurement of PPGs in these patients. An existing LPM of the liver blood circulation was applied and tuned to simulate patient-specific liver hemodynamics. Geometries were collected from seven adult Fontan patients and used to evaluate model parameters. The model was solved and tuned using waveform measurements of flows, inlet and outlet pressures. The predicted ratio of portal to hepatic venous pressures is comparable to in vivo measurements. The results confirmed that HVPG is not suitable for Fontan patients, as it would underestimate the portal pressures gradient by a factor of 3 to 4. Our patient-specific liver model provides an estimate of the pressure drop across the liver, which differs from the clinically used metric HVPG. This work represents a first step toward models suitable to assess liver health in Fontan patients and improve its long-term management.


  • Open Access

    Fatty Acid Binding Protein 4—A Circulating Protein Associated with Peripheral Arterial Disease in Diabetic Patients

    by Abdelrahman Zamzam, Muzammil H. Syed, Elisa Greco, Mark Wheatcroft, Shubha Jain, Hamzah Khan, Krishna K. Singh, Thomas L. Forbes, Ori Rotstein, Rawand Abdin, et al.

    Diabetic patients with peripheral arterial disease (PAD) often suffer from poor clinical outcomes such as limb-loss. Fatty acid binding protein 4 (FABP4) is mainly expressed by adipocytes and is known to play a significant role in the development of atherosclerosis. In this study, we sought to investigate whether FABP4 is associated with PAD in patients with type 2 diabetes mellitus (DM). FABP4 plasma levels were studied in 119 diabetic patients with PAD (DM-PAD) and 49 diabetic patients without PAD (DM-noPAD) presenting to St. Michael’s Hospital between October 2017 and September 2018. Levels of FABP4 in DM-PAD patients (23.34 ± 15.27 ng/mL) were found to be over two-fold higher than the levels in DM-noPAD patients (10.3 ± 7.59 ng/mL). Regression analysis demonstrated a significant association between FABP4 levels and DM-PAD after adjusting for age, sex, prior history of coronary arterial disease and white blood cells count (OR, 2.77; 95% CI, 1.81–4.31; p-value = 0.001). Relative to DM-noPAD controls, plasma FABP4 levels in DM-PAD patients were noted to be inversely correlated with the ankle brachial index (ABI; r= −0.374, p-value < 0.001). The diagnostic ability of FABP4 was investigated using receiver operator curves (ROC) and area under the curve (AUC) analysis. FABP4 had an AUC of 0.79, which improved to 0.86 after adjusting for age, sex and prior history of coronary arterial disease. This raises a possibility of utilizing FABP4 as a biomarker for diagnosing PAD in diabetic patients.